Development of a new assessment strategy in psychosomatic medicine: The diagnostic criteria for psychosomatic research

Advances in Psychosomatic Medicine

Volumn 28, Issue , 2007, Pages 1-20

  Fabbri, S ^a,b   Fava, G ^a,c   Sirri, L ^a   Wise, T ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; HUMAN; METHODOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOSOMATIC DISORDER; PSYCHOSOMATICS;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOSOMATIC MEDICINE;

EID: 34547989250     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000106793     Document Type: Article

References (130)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental disorders, ed 3, Washington, American Psychiatric Association, 1980.
2. Fava GA: The concept of psychosomatic disorder. Psychother Psychosom 1992;58:1-12.
3. Kellner R: Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994;61:4-24.
4. Lipowski ZJ: Somatization. Am J Psychiatry 1987;47:160-167.
5. Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M: Somatoform disorders: time for a new approach in DSM-V Am J Psychiatry 2005;162:847-855.
6. Sensky T: Somatization: syndromes or processes? Psychother Psychosom 1994;61:1-3.
7. Wise TN, Birket-Smith TN: The somatoform disorders for DSM-V: the need for changes in process and content. Psychosomatics 2000;43:437-440.
8. Starcevic V: Somatoform disorders and the DSM-V. Psychosomatics 2006;47:277-281.
9. Hiller W, Rief W: Why DSM-III was right to introduce the concept of somatoform disorders. Psychosomatics 2005;46:105-108.
10. Noyes R, Stuart S, Watson DB, Langbehn DR: Distinguishing between hypochondriasis and somatization disorder. Psychother Psychosom 2006;75:270-281.
11. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63; 1-8.
12. Pilowsky I: Abnormal Illness Behaviour, Chichester, Wiley, 1997.
13. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders, Geneva, World Health Organization, 1992.
14. Beresnevaité M, Taylor GJ, Bagby RM: Assessing alexithymia and type A behavior in coronary heart disease patients: a multimethod approach. Psychother Psychosom 2007;76:186-192.
15. Galeazzi GM, Ferrari S, Mackinnon A, Rigatelli M: Interrater reliability, prevalence and relation to ICD-10 diagnoses of the Diagnostic Criteria for Psychosomatic Research in consultation-liaison psychiatry patients. Psychosomatics 2004;45:386-393.
16. Grandi S, Fabbri S, Tossani E, Mangelli L, Branzi A, Magelli C: Psychological evaluation after cardiac transplantation. Psychother Psychosom 2001;70:176-183.
17. Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L: Use of the Diagnostic Criteria for Psychosomatic Research in oncology. Psychother Psychosom 2005;74:100-107.
18. Mangelli L, Fava GA, Grandi S, Grassi L, Ottolini F, Porcelli P, Rafanelli C, Rigatelli M, Sonino N: Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry 2005;66:391-394.
19. Mangelli L, Fava GA, Grassi L, Ottolini F, Paolini S, Porcelli P, Rafanelli C, Rigatelli M, Sonino N: Irritable mood in Italian patients with medical disease. J Nerv Ment Dis 2006;194:226-228.
20. Mangelli L, Semprini F, Sirri L, Fava GA, Sonino N: Use of the Diagnostic Criteria for Psychosomatic Research (DCPR) in a community sample. Psychosomatics 2006;47:143-146.
21. Ottolini F, Modena MG, Rigatelli M: Prodromal symptoms in myocardial infarction. Psychother Psychosom 2005;74:323-327.
22. Picardi A, Pasquini P, Abeni D, Fassone G, Mazzotti E, Fava GA: Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom 2005;74:315-322.
23. Picardi A, Porcelli P, Pasquini P, Fassone G, Mazzotti E, Lega I, Ramieri L, Sagoni E, Abeni D, Tiago A, Fava GA: Integration of multiple criteria for psychosomatic assessment of dermatological patients. Psychosomatics 2006;47:122-128.
24. Porcelli P, de Carne M, Fava GA: Assessing somatization in functional gastrointestinal disorders Integration of different criteria. Psychother Psychosom 2000;69:198-204.
25. Porcelli P, de Carne M, Todarello O: Prediction of treatment outcome of patients with functional gastrointestinal disorders by the Diagnostic Criteria for Psychosomatic Research. Psychother Psychosom 2004; 73:166-173.
26. Rafanelli C, Roncuzzi R, Finos L, Tossani E, Tomba E, Mangelli L, Urbinati S, Pinelli G, Fava GA: Psychosocial assessment in cardiac rehabilitation. Psychother Psychosom 2003;72:343-349.
27. Rafanelli C, Roncuzzi R, Milaneschi Y, Tomba E, Colistro MC, Pancaldi LG, Di Pasquale G: Stressful life events, depression and demoralization as risk factors for acute coronary heart disease. Psychother Psychosom 2005;74:179-184.
28. Rafanelli C, Roncuzzi R, Milaneschi Y: Minor depression as a cardiac risk factor after coronary artery bypass surgery. Psychosomatics 2006;47:289-295.
29. Sonino N, Navarrini C, Ruini C, Ottolini F, Paoletta A, Fallo F, Boscaro M, Fava GA: Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004;73:78-83.
30. Sonino N, Fallo F, Fava GA: Psychological aspects of primary aldosteronism. Psychother Psychosom 2006;75:327-330.
31. Fukunishi I, Hosaka T, Aoki T, Azekawa T, Ota A, Miyaoka H: Criterion-related validity of diagnostic criteria for alexithymia in a general hospital psychiatric setting. Psychother Psychosom 1996;65:82-85.
32. Littman AB: Review of psychosomatic aspects of cardiovascular disease. Psychother Psychosom 1993;60:148-167.
33. Kellner R: Somatization and Hypochondriasis. New York, Praeger, 1986.
34. Kellner R: Abridged Manual of the Illness Attitude Scale. Albuquerque, Universtity of New Mexico, 1987.
35. Kellner R, Abbott P, Winslow WW, Pathak D: Fears, beliefs, and attitudes in DSM-III hypochondriasis. J Nerv Ment Dis 1987;175:20-25.
36. Fava GA, Grandi S: Differential diagnosis of hypochondriacal fears and beliefs. Psychother Psychosom 1991;55:114-119.
37. Bartolucci G, Savron G, Fava GA, Grandi S, Trombini G, Orlandi C: Psychological reactions in thermography and mammography, Stress Med 1989;5:195-199.
38. Ryle JA: Angor animi, or the sense of dying. Guys Hosp Rep 1928;78:230-235.
39. Fava GA, Kellner R, Zielenzy M, Grandi S: Hypochondriacal fears and beliefs in agoraphobia. J Affect Disord 1988;14:239-244.
40. Fava GA, Grandi S, Saviotti FM, Conti S: Hypochondriasis with panic attacks. Psychosomatics 1990;31:351-353.
41. Morselli E: Sulla dismorfofobia e sulla tafefobia. Boll Reale Accad Med Genova 1891;6:5-14.
42. Mayer-Gross W, Slater E, Roth M: Clinical Psychiatry. London, Doilliere Tindall, 1969.
43. Bianchi GN: Origins of disease phobia. Aust N Z J Psychiatry 1971;5:241-257.
44. Ryle JA: Nosophobia. Br J Psychiatry 1948;94:1-17.
45. Conti S, Savron G, Bartolucci G, Grandi S, Magelli C, Semprini F, Saviotti FM, Trombini G, Fava GA, Magnani B: Cardiac neurosis and psychopathology. Psychother Psychosom 1989;52: 88-91.
46. Noyes R, Carney CP, Langbehn DR: Specific phobia of illness: search for a new subtype. J Anxiety Disord 2004; 18:531-545.
47. Pilowsky I: Dimensions of hypochondriasis. Br J Psychiatry 1967;113:89-93.
48. Warwick HMC, Marks IM: Behavioural treatment of illness phobia and hypochondriasis. Br J Psychiatry 1998;152:239-241.
49. Wesner RB, Noyes R: Imipramine an effective treatment for illness phobia. J Affect Disord 1991;22:43-48.
50. Freud A: The Ego and the Mechanisms of Defense, London, Hogarth, 1961.
51. Lazarus RS: The costs and benefits of denial; in Breznitz S (ed): The Denial of Stress. New York, International Universities Press, 1983.
52. Goldbeck R: Denial in physical illness. J Psychosom Res 1997;43:575-593.
53. Breznitz S: The seven kinds of denial; in Breznitz S (ed): The Denial of Stress. New York, International Universities Press, 1983.
54. Garay-Sevilla ME, Malacara JM, Gutiérrez-Roa A, Gonzalez E: Denial of disease in Type 2 diabetes mellitus: its influence on metabolic control and associated factors. Diabetic Med 1999:16: 238-244.
55. Kreitler S: Denial in cancer patients. Cancer Invest 1999;17:514-534.
56. Young LD, Schweiger J, Beitzinger J, McManus R, Bloedel C, Koob J: Denial in heart transplant candidates. Psychother Psychosom 1991;55:141-144.
57. Ben-Zur H, Breznitz S, Wardi N, Berzon Y: Denial of HIV/AIDS and preventive behaviour among Israeli adolescents. J Adolesc 2000;23:157-174.
58. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, Washington, American Psychiatric Association, 1994.
59. Appelbaum PS: Why denial of physical illness is not a 'diagnosis'. Int J Psychiatry Med 1998;28: 479-482.
60. Muskin PR, Feldhammer T, Gelfand JL, Strauss DH: Maladaptive denial of physical illness: a usenil new 'diagnosis'. Int J Psychiatry Med 1998;28:463-477.
61. Strauss DH, Spitzer RL, Muskin PR: Maladaptive denial of physical illness: a proposal for DSM-IV Am J Psychiatry 1990;147:1168-1172.
62. Creed F, Barsky AA: Systematic review of the epidemiology of somatization disorder and hypochondriasis. J Psychosom Res 2004;56:391-408.
63. Kroenke K, Swindle R: Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000;69:205-215.
64. Stone J, Smyth R, Carson A, Lewis S, Prescott R, Warlow C, Sharpe M: Systematic review of misdiagnosis of conversion symptoms and 'hysteria'. BMJ 2005;331:989.
65. Engel GL: Conversion symptoms; in MacBryde CM, Blacklow RS (eds): Signs and Symptoms. Philadelphia, Lippincott, 1970, pp 650-669.
66. Stone J, Smyth R, Carson A, Warlow C, Sharpe M: La belle indifférence in conversion symptoms and hysteria. Br J Psychiatry 2006;188:204-209.
67. Lipowski ZJ: Physical illness and psychopathology. Int J Psychiatry Med 1974;5:483-497.
68. Daie N, Witztum E: Short-term strategic treatment in traumatic conversion reaction. Am J Psychother 1991;45:335-347.
69. Diseth TH, Christie HJ: Trauma-related dissociative (conversion) disorders in children and adolescents - an overview of assessment tools and treatment principles. Nord J Psychiatr 2005;59: 278-292.
70. Krull F, Schifferdeker M: Inpatient treatment of conversion disorder: a clinical investigation of outcome. Psychother Psychosom 1990;53:161-165.
71. Wald J, Taylor S, Scamvougeras A: Cognitive behavioural and neuropsychiatric treatment of posttraumatic conversion disorder: a case study. Cogn Behav Ther 2004;33:12-20.
72. Fava GA, Magelli C, Savron G, Conti S, Bartolucci G, Grandi S, Semptini F, Saviotti FM, Belluardo P, Magnani B: Neurocirculatory asthenia. Acta Psychiatr Scand 1994;89:314-319.
73. Kellner R: Psychosomatic Syndromes and Somatic Symptoms. Washington, American Psychiatric Press, 1991.
74. Engel GL: The death of a twin, Int J Psychoanal 1975;56:23-40.
75. Hilgard JR: Anniversary reactions in parents precipitated by children. Psychiatry 1953;16:73-80.
76. Hilgard JR, Newman MF: Anniversaries in mental illness. Psychiatry 1959;22:113-121.
77. Chapman AH: The concept of nemesis in psychoneurosis. J Nerv Ment Dis 1959;129:29-34.
78. Frank JD: Psychotherapy: the restoration of morale. Am J Psychiatry 1974; 131:271-274.
79. Frank JD, Frank JB: Persuasion and Healing: a Comparative Study of Psychotherapy. Baltimore, Johns Hopkins University Press, 1993.
80. Slavney PR: Diagnosing demoralization in consultation psychiatry. Psychosomatics 1999;40: 325-329.
81. Dohrenwend BP, Shrout PE, Egri G, Mendelsohn FS: Nonspecific psychological distress and other dimensions of psychopathology, Arch Gen Psychiatry 1980;37:1229-1236.
82. de Figueiredo JM: Depression and demoralization: phenomenologic differences and research perspectives, Compr Psychiatry 1993;34:308-311.
83. Schmale AH, Engel GL: The giving up-given up complex illustrated on film. Arch Gen Psychiatry 1967;17:133-145.
84. Clarke DM, Kissane DW: Demoralization: its phenomenology and importance. Aust NZJ Psychiatry 2002;36:733-742,
85. Grossarth-Maticek R, Bastiaans J, Kanazir DT: Psychosocial factors as strong predictors of mortality from cancer, ischaemic heart disease and stroke: the Yugoslav prospective study, J Psychosom Res 1985;29:167-176,
86. Schuitemaker GE, Dinant GJ, van der Pol GA, Appels A: Assessment of vital exhaustion and identification of subjects at increased risk of myocardial infarction in general practice. Psychosomatics 2004;45:414-418.
87. Beck AT, Weissman A, Lester D, Trexler L: The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974;42:861-865.
88. Clarke DM, Smith GC, Dowe DL, McKenzie DP: An empirically derived taxonomy of common distress syndromes in the medically ill. J Psychosom Res 2003;54:323-330.
89. Feldman D, Rabinowitz J, Yehuda YB: Detecting psychological distress among patients attending secondary health care clinics. Gen Hosp Psychiatry 1995;17:425-432.
90. Snaith RP, Taylor CM: Irritability. Br J Psychiatry 1985;147:127-136.
91. Fava GA: Irritable mood and physical illness. Stress Med 1987;3:293-299.
92. Fava M: Depression with anger attacks. J Clin Psychiatry 1998;59:18-22.
93. Fava GA, Grandi S, Rafanelli C, Saviotti FM, Ballin M, Pesarin F: Hostility and irritable mood in panic disorder with agoraphobia. J Affect Disord 1993;29:213-217.
94. Winkler D, Pjrek E, Kasper S: Anger attacks in depression - evidence for a male depressive syndrome. Psychother Psychosom 2005;74:303-307.
95. Fava GA: Affective disorders and endocrine disease, New insights from psychosomatic studies. Psychosomatics 1994;35:341-353.
96. Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallet AJ: A meta-analytic review of research on hostility and physical health. Psychol Bull 1996;119:322-348.
97. Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino RB, Benjamin EJ: Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation 2004;109:1267-1271.
98. Ketterer MW, Mahr G, Goldberg AD: Psychological factors affecting a medical condition: ischemic coronary heart disease. J Psychosom Res 2000;48:357-367.
99. Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE: Functional gastrointestinal disorders: psychological, social, and somatic features, Gut 1998;42:414-420.
100. Fukunishi I, Hosaka T, Rahe RH: Are abnormal gastrofiberscopic findings related to hostility with poor social support or to negative responses to stress? J Psychosom Res 1996;41:337-342.
101. Welgan P, Meshkinpour H, Ma L: Role of anger in antral motor activity in irritable bowel syndrome. Dig Dis Sci 2000;45:248-251.
102. Miller TQ, Markides KS, Chiriboga DA, Ray LA: A test of the psychosocial vulnerability and health behavior models of hostility: results from an 11-year follow-up study of Mexican Americans. Psychosom Med 1995;57:572-581.
103. Friedman M, Rosenman RH: Association of specific overt behavior pattern with blood and cardiovascular findings. JAMA 1959;169:1286-1295.
104. Friedman M, Rosenman RH: Type A Behavior and Your Heart. New York, Knopf, 1974.
105. Fava M, Littman A, Halperin P: Neuroendocrine correlates of the type A behavior pattern: a review and new hypotheses. Int J Psychiatry Med 1987;17:289-307.
106. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M: Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 85 years. JAMA 1975;233:872-877.
107. Haynes S, Feinleib M, Levine S, Scotch N, Kannel W: The relationship of psychosocial factors to coronary heart disease in the Framingham Study: prevalence of coronary heart disease. Am J Epidemiol 1978;107:384-389.
108. Cole SR, Kawachi I, Liu S, Gaziano JM, Manson JE, Buring JE, Hennekens CH: Time urgency and risk of non-fatal myocardial infarction. Int J Epidemiol 2001;30:363-369.
109. Friedman M: Type A Behavior: Its Diagnosis and Treatment. New York, Plenum Press, 1996.
110. Sparagon B, Friedman M, Breall WS, Goodwin ML, Fleischmann N, Ghandour G: Type A behavior and coronary atherosclerosis. Atherosclerosis 2001;156:145-149.
111. Jenkins CD, Rosenman RH: Development of an objective test for the determination of the coronaryprone behavior pattern in employed men. J Chronic Dis 1967;20:371-379.
112. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL: Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129-133.
113. Ornish D, Scherwitz LW, Billings JH, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ: Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998;280:2001-2007.
114. Sebregts EH, Falger PR, Bar FW: Risk factor modification through nonpharmacological interventions in patients with coronary heart disease. J Psychosom Res 2000;48:425-441.
115. Michaelsen A, Grossman P, Lehmann N, Knoblauch NTM, Paul A, Moebius S, Buddie T, Dobos GJ: Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease. Psychother Psychosom 2005;74:344-352.
116. Sifneos PE: The prevalence of alexithymic characteristics in psychosomatic patients. Psychother Psychosom 1973;22:255-262.
117. Sifneos PE: Affect, emotional conflict, and deficit: an overview. Psychother Psychosom 1991;56: 116-122.
118. Porcelli P, Taylor GJ, Bagby RM, De Carne M: Alexithymia and functional gastrointestinal disorder. Psychother Psychosom 1999;68:263-269.
119. Bach M, Bach D: Alexithymia in somatoform disorders and somatic diseases. Psychother Psychosom 1996;65:150-152.
120. Honkalampi K, Saarinen P, Hintikka J, Virtanen V, Viinamaki H: Factors associated with alexithymia in patients suffering from depression. Psychother Psychosom 1999;68:270-275.
121. Iancu I, Horesh N, Offer D, Dannon PN, Lepkifker E, Kotler M: Alexithymia, affect intensity and emotional range in suicidal patients. Psychother Psychosom 1999;68:276-280.
122. Berenbaum H, Davis R, McGrew J: Alexithymia and the interpretation of hostile-provoking situations. Psychother Psychosom 1998;67:254-258.
123. Kooiman CG, Spinhoven P, Truiisburg RW, Roojmans HGM: Perceived parental attitude, alexithymia and defense style in psychiatric outpatients. Psychother Psychosom 1998;67:81-87.
124. Taylor GJ: Recent developments in alexithymia theory and research. Can J Psychiatry 2000;45: 134-142.
125. Lumley MA, Stettner L, Wehmer F: How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 1996;41:505-518.
126. Kissen DM: The significance of syndrome shift and late syndrome association in psychosomatic medicine. J Nerv Ment Dis 1963; 136:34-42.
127. Fava GA, Sonino N: The clinical domains of psychosomatic medicine. J Clin Psychiatry 2005;66:849-858.
128. Halliday JL: The significance of the concept of a psychosomatic affection. Psychosom Med 1945;7:240-245.
129. Fava GA: A different medicine is possible, Psychother Psychosom 2006;75:1-3.
130. Fava GA, Fabbri S, Sirri L, Wise TN: Psychological factors affecting medical condition: a new proposal for DSM-V Psychosomatics 2007;48:103-111.